Loading the security overview…
Where the tokens are
Standardised from the company’s filings, newest period first, labelled with the company’s own fiscal calendar. A line the company does not report is left off rather than shown as zero; margins and free cash flow are worked out here, and only where every input is present.
| Line item | Q2 FY262026-06-30 | Q1 FY262026-03-31 | Q4 FY252025-12-31 | Q3 FY252025-09-30 | Q2 FY252025-06-30 | Q1 FY252025-03-31 | Q4 FY242024-12-31 | Q3 FY242024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.74B | $1.43B | $1.43B | $1.31B | $1.33B | $1.08B | $1.23B | $1.35B |
| Cost of revenue | $1.15B | $927.77M | $1.23B | $1.19B | $1.13B | $920.58M | $1.09B | $1.46B |
| Gross profit | $590.30M | $500.97M | $197.93M | $117.61M | $196.88M | $156.30M | $138.21M | −$104.03M |
| Gross margin | 33.9% | 35.1% | 13.9% | 9.0% | 14.8% | 14.5% | 11.2% | -7.7% |
| Research and development | $3.67M | $9.17M | $12.18M | $12.67M | $12.44M | $14.10M | $20.02M | $22.40M |
| Selling, general and administrative | $126.35M | $137.41M | $155.50M | $138.58M | $132.46M | $123.50M | $136.00M | $154.25M |
| Operating expenses | $137.36M | $172.44M | $415.32M | $334.60M | $149.35M | $136.54M | $133.81M | $1.00B |
| Operating income | $452.94M | $328.52M | −$217.39M | −$216.99M | $47.53M | $19.76M | $4.40M | −$1.11B |
| Operating margin | 26.0% | 23.0% | -15.2% | -16.6% | 3.6% | 1.8% | 0.4% | -81.9% |
| EBITDA | $616.08M | $512.20M | $193.96M | $130.84M | $220.71M | $180.45M | $145.30M | −$117.18M |
| Interest expense | −$30.92M | −$33.12M | −$57.78M | −$50.96M | −$49.94M | −$48.98M | −$44.70M | −$47.76M |
| Income before taxes | $441.65M | $254.20M | −$284.99M | −$239.15M | −$8.97M | −$18.97M | $76.73M | −$1.18B |
| Income taxes | $94.00M | $21.51M | $157.33M | −$30.57M | $34.09M | −$3.98M | $10.61M | $110.85M |
| Net income | $499.21M | $328.98M | −$401.76M | −$147.94M | $35.19M | $49.30M | $85.11M | −$1.06B |
| Net margin | 28.6% | 23.0% | -28.1% | -11.3% | 2.6% | 4.6% | 6.9% | -78.3% |
| EPS, basic | $3.72 | $2.35 | −$3.87 | −$1.72 | −$0.16 | $0.00 | $0.29 | −$9.45 |
| EPS, diluted | $3.52 | $2.34 | −$3.87 | −$1.72 | −$0.16 | $0.00 | $0.29 | −$9.45 |
| Diluted shares | 136.21M | 118.61M | 117.70M | 117.69M | 117.67M | 117.60M | 117.55M | 117.54M |
Figures describe Albemarle shares, not any token. As of Aug 5, 2026, from Massive's standardised financials. The company reports these figures; a token's issuer holds the shares and reports nothing of its own here.